# Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine

> **NCT05948553** · PHASE2 · RECRUITING · sponsor: **Global Coalition for Adaptive Research** · enrollment: 200 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Intervention A Fluoxetine Hydrochloride (HCl)
- **DRUG:** Intervention A Placebo

## Key facts

- **NCT ID:** NCT05948553
- **Lead sponsor:** Global Coalition for Adaptive Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-02
- **Primary completion:** 2026-03
- **Final completion:** 2026-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05948553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05948553, "Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05948553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*